MELANIE BERMAN: Open Payments
NPI 1922759422 · SPRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 40 payments from 17 companies in 2025. Trend: 2023 $2,686 · 2024 $3,541 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| ABBVIE INC. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Bausch Health US, LLC | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Dexcom, Inc. | 1 | $42 |
| Esperion Therapeutics, Inc. | 2 | $36 |
Products named: Ozempic, Kerendia, CAPLYTA, WELLBUTRIN, Auvelity, LEQVIO, Dexcom G6 Transmitter, VRAYLAR.
Industry payments across PA — which companies pay providers there.
